$GLYC GLYCOMIMETICS INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in GLYCOMIMETICS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in GLYCOMIMETICS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in GLYCOMIMETICS INC for free.

CIK Number: 0001253689
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: GLYC
Company Address: 9708 MEDICAL CENTER DRIVE ROCKVILLE 20850
Phone number: 240-243-1201

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.

Market Capitalization: $140.70M
Prev close: $6.26
Average Daily Volume: 43,500
Days Low: $5.83
Year Low: $3.70
Year High: $9.25

GLYCOMIMETICS INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 27 2021GLYCGLYCOMIMETICS INCAndrews Patricia SDirectorOption ExerciseA2.5510,50026,77510,500
May 27 2021GLYCGLYCOMIMETICS INCAndrews Patricia SDirectorGrantA0.005,25005,2500 to 5.3 K
May 27 2021GLYCGLYCOMIMETICS INCGoldberg Mark AlanDirectorOption ExerciseA2.5510,50026,77510,500
May 27 2021GLYCGLYCOMIMETICS INCGoldberg Mark AlanDirectorGrantA0.005,25005,2500 to 5.3 K
Jan 22 2021GLYCGLYCOMIMETICS INCGirard ArmandSVP, Chief Business ...Option ExerciseA3.8150,000190,50050,000
Jan 22 2021GLYCGLYCOMIMETICS INCGirard ArmandSVP, Chief Business ...GrantA0.0025,000025,0000 to 25 K
Jan 22 2021GLYCGLYCOMIMETICS INCHahn Brian M.SVP Finance, CFOOption ExerciseA3.8169,000262,89069,000
Jan 22 2021GLYCGLYCOMIMETICS INCHahn Brian M.SVP Finance, CFOGrantA0.0034,500039,7605.3 K to 39.8 K (+655.89 %)
Jan 22 2021GLYCGLYCOMIMETICS INCThackray Helen M.SVP Clinical Develo ...Option ExerciseA3.8169,000262,89069,000
Jan 22 2021GLYCGLYCOMIMETICS INCThackray Helen M.SVP Clinical Develo ...GrantA0.0034,5000183,115148.6 K to 183.1 K (+23.21 %)
Jan 22 2021GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...Option ExerciseA3.8169,000262,89069,000
Jan 22 2021GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...GrantA0.0034,5000324,260289.8 K to 324.3 K (+11.91 %)
Jan 22 2021GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseA3.81192,500733,425192,500
Jan 22 2021GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOGrantA0.0096,2500452,314356.1 K to 452.3 K (+27.03 %)
Dec 30 2020GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseM1.12130,821146,5200

View all GLYCOMIMETICS INC insider transactions.